Janus Henderson Group PLC Sells 202,233 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Janus Henderson Group PLC reduced its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 18.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 899,240 shares of the company's stock after selling 202,233 shares during the period. Janus Henderson Group PLC owned about 1.03% of HealthEquity worth $73,604,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. International Assets Investment Management LLC acquired a new stake in HealthEquity during the 2nd quarter valued at approximately $35,000. Paladin Wealth LLC bought a new stake in shares of HealthEquity during the 3rd quarter valued at about $39,000. GAMMA Investing LLC grew its stake in HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company's stock worth $51,000 after purchasing an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in HealthEquity in the second quarter worth approximately $73,000. Finally, 1620 Investment Advisors Inc. acquired a new position in HealthEquity in the third quarter valued at approximately $112,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. BTIG Research raised their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Mizuho initiated coverage on HealthEquity in a research report on Wednesday. They set an "outperform" rating and a $126.00 target price on the stock. Bank of America lifted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. Finally, Royal Bank of Canada restated an "outperform" rating and set a $92.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $109.64.

HealthEquity Trading Down 0.6 %

Shares of HealthEquity stock traded down $0.64 during trading on Friday, reaching $100.21. 885,402 shares of the stock were exchanged, compared to its average volume of 625,670. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $105.82. The firm has a market cap of $8.75 billion, a price-to-earnings ratio of 84.04, a price-to-earnings-growth ratio of 1.59 and a beta of 0.55. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock's fifty day moving average is $92.02 and its 200 day moving average is $83.44.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.